Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia
Fibromyalgia
About this trial
This is an interventional treatment trial for Fibromyalgia focused on measuring Fibromyalgia, Electroencephalograph (EEG) biofeedback, Electromagnetic stimulation, Neurofeedback, Neurotherapy, Complementary and Alternative Medicine
Eligibility Criteria
Inclusion criteria: Diagnosis of fibromyalgia with symptoms for at least 1 year Self-report of having attention/concentration, memory, multi-tasking or other thinking difficulties Able to read and understand English Able to attend treatment sessions weekly and return for planned follow-ups Appropriate balance of average delta (<4 Hertz) EEG waveband and alpha (approximately 4-8 Hertz) EEG waveband amplitude on LENS screening (to be determined by study personnel); Exclusion criteria: Other chronic pain condition of major significance Current chronic viral infection Current other unstable medical condition History of spinal, including neck, surgery Psychological screening indicates psychotic, suicidal, homicidal, and/or substance abusing Use of long-acting opioid medication taken on a continuous 24-hour dosing schedule Current involved in litigation regarding pain condition or seeking disability History of electroconvulsive therapy
Sites / Locations
- Oregon Health & Science University